Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver
- 17 July 2006
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 79 (8), 737-743
- https://doi.org/10.1016/j.lfs.2006.02.037
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (17300208)
This publication has 39 references indexed in Scilit:
- Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV–EN study)Hepatology Research, 2005
- Effects of liver failure on branched-chain α-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failureJournal of Hepatology, 2004
- AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) SignalingPublished by Elsevier BV ,2002
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of TranslationAnnual Review of Biochemistry, 1999
- Bidirectional modulation of insulin action by amino acids.JCI Insight, 1998
- Initiation of Protein Synthesis in Eukaryotic CellsJBIC Journal of Biological Inorganic Chemistry, 1996
- Regulation by induction of branched-chain 2-oxo acid dehydrogenase complex in clofibrate-fed rat liverBiochemical and Biophysical Research Communications, 1990
- Branched-Chain Amino Acid MetabolismAnnual Review of Nutrition, 1984
- Paradoxical Effects of Clofibrate on Liver and Muscle Metabolism in RatsJCI Insight, 1979